{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:22:45Z","timestamp":1792498965712,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis, inflammation and fibrosis, which might progress to cirrhosis. Human NASH is associated with metabolic syndrome (MS). Currently, rodent NASH models either lack significant fibrosis or MS. ApoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice are a MS model used in cardiovascular research. The aim of this work was to establish and characterise a novel mouse NASH model with significant fibrosis and MS. ApoE<jats:sup>\u2212\/\u2212<\/jats:sup> and wild-type mice (wt) were fed either a western-diet (WD), methionine-choline-deficient-diet (MCD) or normal chow. Liver histology, RT-PCR, hepatic hydroxyproline content, triglycerides and cholesterol levels and fasting glucose levels assessed hepatic steatosis, inflammation and fibrosis. Further, portal pressure was measured invasively and kidney pathology was assessed by histology. ApoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice receiving WD showed abnormal glucose tolerance, hepatomegaly, weight gain and full spectrum of NASH including hepatic steatosis, fibrosis and inflammation, with no sign of renal damage. MCD-animals showed less severe liver fibrosis, but detectable renal pathological changes, besides weight loss and unchanged glucose tolerance. This study describes a murine NASH model with distinct hepatic steatosis, inflammation and fibrosis, without renal pathology. ApoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice receiving WD represent a novel and fast model with all characteristic features of NASH and MS well suitable for NASH research.<\/jats:p>","DOI":"10.1038\/srep12931","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T13:09:16Z","timestamp":1439298556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":176,"title":["Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis"],"prefix":"10.1038","volume":"5","author":[{"given":"Robert","family":"Schierwagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Mayb\u00fcchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishka","family":"Hittatiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"B\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank E.","family":"Uschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Reul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Boor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jogchum","family":"Plat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"L\u00fctjohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"key":"BFsrep12931_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","volume":"5","author":"DG Tiniakos","year":"2010","unstructured":"Tiniakos, D. G., Vos, M. B. & Brunt, E. M. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5, 145\u2013171 (2010).","journal-title":"Annu Rev Pathol"},{"key":"BFsrep12931_CR2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"Marchesini, G. et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1844\u20131850 (2001).","journal-title":"Diabetes"},{"key":"BFsrep12931_CR3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal, A. J. et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183\u20131192 (2001).","journal-title":"Gastroenterology"},{"key":"BFsrep12931_CR4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","volume":"43","author":"AJ Sanyal","year":"2006","unstructured":"Sanyal, A. J. et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 43, 682\u2013689 (2006).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day, C. P. & James, O. F. Steatohepatitis: a tale of two \u2018hits\u2019? Gastroenterology 114, 842\u2013845 (1998).","journal-title":"Gastroenterology"},{"key":"BFsrep12931_CR6","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836\u20131846 (2010).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","volume":"4","author":"M Mar\u00ed","year":"2006","unstructured":"Mar\u00ed, M. et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 4, 185\u2013198 (2006).","journal-title":"Cell Metab."},{"key":"BFsrep12931_CR8","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.21874","volume":"46","author":"N Matsuzawa","year":"2007","unstructured":"Matsuzawa, N. et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46, 1392\u20131403 (2007).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gut.2007.123240","volume":"57","author":"D Cassiman","year":"2008","unstructured":"Cassiman, D. & Jaeken, J. NASH may be trash. Gut 57, 141\u2013144 (2008).","journal-title":"Gut"},{"key":"BFsrep12931_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","volume":"6","author":"C Liedtke","year":"2013","unstructured":"Liedtke, C. et al. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis & Tissue Repair 6, 19 (2013).","journal-title":"Fibrogenesis & Tissue Repair"},{"key":"BFsrep12931_CR11","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","volume":"18","author":"Y Takahashi","year":"2012","unstructured":"Takahashi, Y., Soejima, Y. & Fukusato, T. Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J. Gastroenterol. 18, 2300\u20132308 (2012).","journal-title":"World J. Gastroenterol."},{"key":"BFsrep12931_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.ATV.14.1.141","volume":"14","author":"RL Reddick","year":"1994","unstructured":"Reddick, R. L., Zhang, S. H. & Maeda, N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler. Thromb. 14, 141\u2013147 (1994).","journal-title":"Arterioscler. Thromb."},{"key":"BFsrep12931_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-511X-10-8","volume":"10","author":"G Song","year":"2011","unstructured":"Song, G. et al. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet. Lipids Health Dis 10, 8 (2011).","journal-title":"Lipids Health Dis"},{"key":"BFsrep12931_CR14","doi-asserted-by":"crossref","first-page":"G553","DOI":"10.1152\/ajpgi.00547.2007","volume":"296","author":"N Ferr\u00e9","year":"2009","unstructured":"Ferr\u00e9, N. et al. Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G553\u2013562 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFsrep12931_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/oby.2009.176","volume":"18","author":"VL King","year":"2010","unstructured":"King, V. L. et al. A Murine Model of Obesity With Accelerated Atherosclerosis. Obesity 18, 35\u201341 (2010).","journal-title":"Obesity"},{"key":"BFsrep12931_CR16","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/hep.23928","volume":"52","author":"M Mart\u00ednez-Clemente","year":"2010","unstructured":"Mart\u00ednez-Clemente, M. et al. Disruption of the 12\/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease. Hepatology 52, 1980\u20131991 (2010).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.23463","volume":"51","author":"M Mart\u00ednez-Clemente","year":"2010","unstructured":"Mart\u00ednez-Clemente, M. et al. 5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice. Hepatology 51, 817\u2013827 (2010).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/labinvest.2014.112","volume":"94","author":"M Kampschulte","year":"2014","unstructured":"Kampschulte, M. et al. Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis and tumorigenesis. Lab. Invest. 94, 1273\u20131282 (2014).","journal-title":"Lab. Invest."},{"key":"BFsrep12931_CR19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0168-8278(02)00102-2","volume":"37","author":"IA Leclercq","year":"2002","unstructured":"Leclercq, I. A., Farrell, G. C., Schriemer, R. & Robertson, G. R. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J. Hepatol. 37, 206\u2013213 (2002).","journal-title":"J. Hepatol."},{"key":"BFsrep12931_CR20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.metabol.2006.11.004","volume":"56","author":"H Nakayama","year":"2007","unstructured":"Nakayama, H. et al. Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis. Metabolism 56, 470\u2013475 (2007).","journal-title":"Metabolism"},{"key":"BFsrep12931_CR21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","volume":"49","author":"CZ Larter","year":"2008","unstructured":"Larter, C. Z., Yeh, M. M., Williams, J., Bell-Anderson, K. S. & Farrell, G. C. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. Journal of Hepatology 49, 407\u2013416 (2008).","journal-title":"Journal of Hepatology"},{"key":"BFsrep12931_CR22","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3945\/jn.109.105858","volume":"139","author":"T Kawasaki","year":"2009","unstructured":"Kawasaki, T. et al. Rats Fed Fructose-Enriched Diets Have Characteristics of Nonalcoholic Hepatic Steatosis. J. Nutr. 139, 2067\u20132071 (2009).","journal-title":"J. Nutr."},{"key":"BFsrep12931_CR23","doi-asserted-by":"crossref","first-page":"17839","DOI":"10.3748\/wjg.v20.i47.17839","volume":"20","author":"Y Simon","year":"2014","unstructured":"Simon, Y. et al. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. World J Gastroenterol 20, 17839\u201317850 (2014).","journal-title":"World J Gastroenterol"},{"key":"BFsrep12931_CR24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","volume":"50","author":"F Caballero","year":"2009","unstructured":"Caballero, F. et al. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. Journal of Hepatology 50, 789\u2013796 (2009).","journal-title":"Journal of Hepatology"},{"key":"BFsrep12931_CR25","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/hep.26342","volume":"58","author":"M Simonen","year":"2013","unstructured":"Simonen, M. et al. Desmosterol in human nonalcoholic steatohepatitis. Hepatology 58, 976\u2013982 (2013).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR26","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1073\/pnas.94.6.2557","volume":"94","author":"SQ Yang","year":"1997","unstructured":"Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. & Diehl, A. M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94, 2557\u20132562 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep12931_CR27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1872-034X.2007.00008.x","volume":"37","author":"M Ito","year":"2007","unstructured":"Ito, M. et al. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol. Res. 37, 50\u201357 (2007).","journal-title":"Hepatol. Res."},{"key":"BFsrep12931_CR28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jhep.2013.02.024","volume":"59","author":"DM Van Rooyen","year":"2013","unstructured":"Van Rooyen, D. M. et al. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome. J. Hepatol. 59, 144\u2013152 (2013).","journal-title":"J. Hepatol."},{"key":"BFsrep12931_CR29","doi-asserted-by":"crossref","first-page":"e30668","DOI":"10.1371\/journal.pone.0030668","volume":"7","author":"V Bieghs","year":"2012","unstructured":"Bieghs, V. et al. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLoS ONE 7, e30668 (2012).","journal-title":"PLoS ONE"},{"key":"BFsrep12931_CR30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/hep.23797","volume":"52","author":"R Kohli","year":"2010","unstructured":"Kohli, R. et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52, 934\u2013944 (2010).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR31","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","volume":"301","author":"M Charlton","year":"2011","unstructured":"Charlton, M. et al. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis and high physiological fidelity to the human condition. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G825\u2013834 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFsrep12931_CR32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","volume":"48","author":"K Wouters","year":"2008","unstructured":"Wouters, K. et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48, 474\u2013486 (2008).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR33","first-page":"1449","volume":"22","author":"S Francque","year":"2010","unstructured":"Francque, S. et al. Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. Eur J Gastroenterol Hepatol 22, 1449\u20131457 (2010).","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFsrep12931_CR34","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.ajpath.2011.07.014","volume":"179","author":"M Itoh","year":"2011","unstructured":"Itoh, M. et al. Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. Am. J. Pathol. 179, 2454\u20132463 (2011).","journal-title":"Am. J. Pathol."},{"key":"BFsrep12931_CR35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","volume":"26","author":"MJ Wolf","year":"2014","unstructured":"Wolf, M. J. et al. Metabolic activation of intrahepatic CD8+T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26, 549\u2013564 (2014).","journal-title":"Cancer Cell"},{"key":"BFsrep12931_CR36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00395-010-0090-7","volume":"105","author":"V Tiyerili","year":"2010","unstructured":"Tiyerili, V. et al. CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res. Cardiol. 105, 465\u2013477 (2010).","journal-title":"Basic Res. Cardiol."},{"key":"BFsrep12931_CR37","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.yjmcc.2011.08.008","volume":"51","author":"FF Hoyer","year":"2011","unstructured":"Hoyer, F. F. et al. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo. J. Mol. Cell. Cardiol. 51, 1007\u20131014 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFsrep12931_CR38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","volume":"61","author":"C Baeck","year":"2012","unstructured":"Baeck, C. et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61, 416\u2013426 (2012).","journal-title":"Gut"},{"key":"BFsrep12931_CR39","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jhep.2012.07.033","volume":"57","author":"S Klein","year":"2012","unstructured":"Klein, S. et al. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects. Journal of Hepatology 57, 1220\u20131227 (2012).","journal-title":"Journal of Hepatology"},{"key":"BFsrep12931_CR40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","volume":"46","author":"J Trebicka","year":"2007","unstructured":"Trebicka, J. et al. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology 46, 242\u2013253 (2007).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR41","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hep.22170","volume":"47","author":"J Trebicka","year":"2008","unstructured":"Trebicka, J. et al. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats. Hepatology 47, 1264\u20131276 (2008).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR42","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","volume":"53","author":"J Trebicka","year":"2010","unstructured":"Trebicka, J. et al. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J. Hepatol. 53, 702\u2013712 (2010).","journal-title":"J. Hepatol."},{"key":"BFsrep12931_CR43","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.23222","volume":"50","author":"J Trebicka","year":"2009","unstructured":"Trebicka, J. et al. Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis. Hepatology 50, 1924\u20131935 (2009).","journal-title":"Hepatology"},{"key":"BFsrep12931_CR44","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1478-3231.2011.02496.x","volume":"31","author":"J Trebicka","year":"2011","unstructured":"Trebicka, J. et al. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver Int. 31, 860\u2013870 (2011).","journal-title":"Liver Int."},{"key":"BFsrep12931_CR45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cmet.2013.01.014","volume":"17","author":"F Von Meyenn","year":"2013","unstructured":"Von Meyenn, F. et al. Glucagon-Induced Acetylation of Foxa2 Regulates Hepatic Lipid Metabolism. Cell Metabolism 17, 436\u2013447 (2013).","journal-title":"Cell Metabolism"},{"key":"BFsrep12931_CR46","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/db10-0778","volume":"60","author":"S Parathath","year":"2011","unstructured":"Parathath, S. et al. Diabetes Adversely Affects Macrophages During Atherosclerotic Plaque Regression in Mice. Diabetes 60, 1759\u20131769 (2011).","journal-title":"Diabetes"},{"key":"BFsrep12931_CR47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak, K. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696\u2013699 (1995).","journal-title":"J. Hepatol."},{"key":"BFsrep12931_CR48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-3-10","volume":"3","author":"S Huss","year":"2010","unstructured":"Huss, S. et al. Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis. Fibrogenesis Tissue Repair 3, 10 (2010).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFsrep12931_CR49","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ki.2011.254","volume":"80","author":"P Boor","year":"2011","unstructured":"Boor, P. et al. The peroxisome proliferator-activated receptor-\u03b1 agonist, BAY PP1, attenuates renal fibrosis in rats. Kidney Int. 80, 1182\u20131197 (2011).","journal-title":"Kidney Int."},{"key":"BFsrep12931_CR50","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1194\/jlr.M200071-JLR200","volume":"43","author":"D L\u00fctjohann","year":"2002","unstructured":"L\u00fctjohann, D. et al. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J. Lipid Res. 43, 1078\u20131085 (2002).","journal-title":"J. Lipid Res."},{"key":"BFsrep12931_CR51","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.105.094136","volume":"316","author":"KM Thelen","year":"2006","unstructured":"Thelen, K. M. et al. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J. Pharmacol. Exp. Ther. 316, 1146\u20131152 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep12931_CR52","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1194\/jlr.M700497-JLR200","volume":"49","author":"SPJ Dullens","year":"2008","unstructured":"Dullens, S. P. J., Mensink, R. P., Bragt, M. C. E., Kies, A. K. & Plat, J. Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice. J. Lipid Res. 49, 790\u2013796 (2008).","journal-title":"J. Lipid Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep12931","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep12931.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep12931.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:55:26Z","timestamp":1672962926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep12931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,10,16]]}},"alternative-id":["BFsrep12931"],"URL":"https:\/\/doi.org\/10.1038\/srep12931","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,11]]},"assertion":[{"value":"8 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12931"}}